Tag Archives: Acquisition

December, 2018

October, 2018

April, 2018

October, 2017

  • 27 October

    Evotec and Tesaro Partner to Discover Novel Immuno-Oncology Agents

    HAMBURG, Germany–(BUSINESS WIRE)–Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and TESARO, Inc. (“TESARO”) today announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immuno-oncology (IO) target. Under the terms of the collaboration, Evotec will apply its integrated drug …

May, 2017

  • 17 May

    Thermo Fisher to Acquire Leading CDMO Patheon for $7.2 Billion

    WALTHAM, Mass. and DURHAM, N.C., May 15, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Patheon N.V. (NYSE: PTHN), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, today announced that their boards of …

April, 2017

March, 2015

  • 5 March

    Novartis Sells its RNAi Assets to Arrowhead Research

    Today, Arrowhead Research Corporation announced that it has acquired Novartis’ entire RNAi business for $10 million in cash and $25 million in stock. The deal gives Arrowhead Novartis’ complete RNAi research and development portfolio and associated assets, including assignment of certain Novartis patents and patent applications related to RNAi therapeutics, …

  • 2 March

    Cardinal Health to Buy Johnson & Johnson’s Cordis for Nearly $2 Billion

    Cardinal Health

    Johnson & Johnson announced that it is selling its Cordis business, which makes vascular technology, to Cardinal Health for approximately $1.94 billion. Cardinal will acquire Cordis for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds plus approximately $46 million of retained net receivables. Cordis is …